Secretory Immunoglobulin a (SigA) Testing in Saliva from End-Stage Patients with Chronic Kidney Disease Undergoing Dialysis Treatment and in Control Healthy Subjects

The purpose of the present study was to measure SIgA levels in saliva in control healthy patients and in patients with end-stage chronic kidney disease (CKD) undergoing dialysis treatment.

Guardado en:
Detalles Bibliográficos
Autores principales: Nenova-Nogalcheva A., Konstantinova D., Pechalova P.
Formato: article
Lenguaje:EN
Publicado: Sciendo 2020
Materias:
R
Acceso en línea:https://doaj.org/article/e9e0b938912c435ba72b7da9b127fcb7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e9e0b938912c435ba72b7da9b127fcb7
record_format dspace
spelling oai:doaj.org-article:e9e0b938912c435ba72b7da9b127fcb72021-12-02T14:59:51ZSecretory Immunoglobulin a (SigA) Testing in Saliva from End-Stage Patients with Chronic Kidney Disease Undergoing Dialysis Treatment and in Control Healthy Subjects0324-175010.2478/amb-2020-0017https://doaj.org/article/e9e0b938912c435ba72b7da9b127fcb72020-07-01T00:00:00Zhttps://doi.org/10.2478/amb-2020-0017https://doaj.org/toc/0324-1750The purpose of the present study was to measure SIgA levels in saliva in control healthy patients and in patients with end-stage chronic kidney disease (CKD) undergoing dialysis treatment.Nenova-Nogalcheva A.Konstantinova D.Pechalova P.Sciendoarticlesalivary igaoral cavityend-stage renal diseaseMedicineRENActa Medica Bulgarica, Vol 47, Iss 2, Pp 18-21 (2020)
institution DOAJ
collection DOAJ
language EN
topic salivary iga
oral cavity
end-stage renal disease
Medicine
R
spellingShingle salivary iga
oral cavity
end-stage renal disease
Medicine
R
Nenova-Nogalcheva A.
Konstantinova D.
Pechalova P.
Secretory Immunoglobulin a (SigA) Testing in Saliva from End-Stage Patients with Chronic Kidney Disease Undergoing Dialysis Treatment and in Control Healthy Subjects
description The purpose of the present study was to measure SIgA levels in saliva in control healthy patients and in patients with end-stage chronic kidney disease (CKD) undergoing dialysis treatment.
format article
author Nenova-Nogalcheva A.
Konstantinova D.
Pechalova P.
author_facet Nenova-Nogalcheva A.
Konstantinova D.
Pechalova P.
author_sort Nenova-Nogalcheva A.
title Secretory Immunoglobulin a (SigA) Testing in Saliva from End-Stage Patients with Chronic Kidney Disease Undergoing Dialysis Treatment and in Control Healthy Subjects
title_short Secretory Immunoglobulin a (SigA) Testing in Saliva from End-Stage Patients with Chronic Kidney Disease Undergoing Dialysis Treatment and in Control Healthy Subjects
title_full Secretory Immunoglobulin a (SigA) Testing in Saliva from End-Stage Patients with Chronic Kidney Disease Undergoing Dialysis Treatment and in Control Healthy Subjects
title_fullStr Secretory Immunoglobulin a (SigA) Testing in Saliva from End-Stage Patients with Chronic Kidney Disease Undergoing Dialysis Treatment and in Control Healthy Subjects
title_full_unstemmed Secretory Immunoglobulin a (SigA) Testing in Saliva from End-Stage Patients with Chronic Kidney Disease Undergoing Dialysis Treatment and in Control Healthy Subjects
title_sort secretory immunoglobulin a (siga) testing in saliva from end-stage patients with chronic kidney disease undergoing dialysis treatment and in control healthy subjects
publisher Sciendo
publishDate 2020
url https://doaj.org/article/e9e0b938912c435ba72b7da9b127fcb7
work_keys_str_mv AT nenovanogalchevaa secretoryimmunoglobulinasigatestinginsalivafromendstagepatientswithchronickidneydiseaseundergoingdialysistreatmentandincontrolhealthysubjects
AT konstantinovad secretoryimmunoglobulinasigatestinginsalivafromendstagepatientswithchronickidneydiseaseundergoingdialysistreatmentandincontrolhealthysubjects
AT pechalovap secretoryimmunoglobulinasigatestinginsalivafromendstagepatientswithchronickidneydiseaseundergoingdialysistreatmentandincontrolhealthysubjects
_version_ 1718389236367884288